Diagnostic Performance of Prothrombin Time and Activated Partial Thromboplastin Time in Children: A Service Evaluation. [PDF]
Gurumurthy G +4 more
europepmc +1 more source
Variation in coagulation factor activity levels cause discrepancies between activated partial thromboplastin time and anti-Xa activity for heparin monitoring: a retrospective observational study. [PDF]
Saito T +16 more
europepmc +1 more source
Laboratory Identification of Lupus Anticoagulant (LA) Using Different Activated Partial Thromboplastin Time (APTT) Assays. [PDF]
Barion BG +7 more
europepmc +1 more source
A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies. [PDF]
Tsukamoto Y +6 more
europepmc +1 more source
Activated partial thromboplastin time prolongation without hemorrhagic dienhesis: a study of a chinese family coexisting with hereditary KNG1 p.Arg240 mutation and --SEA/αα genotype thalassemia. [PDF]
Bai Z +8 more
europepmc +1 more source
From Activated Partial Thromboplastin Time to Antifactor Xa and Back Again. [PDF]
May JE +4 more
europepmc +1 more source
Survey of clot waveform analysis of normal activated partial thromboplastin time in patients with cirrhosis and sepsis at Le Van Thinh hospital. [PDF]
Phuong Linh TQ +3 more
europepmc +1 more source
Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population. [PDF]
Zhang F +11 more
europepmc +1 more source
A narrative literature review on the clinical utility of activated partial thromboplastin time and anti-factor Xa activity assays in cancer patients with anticoagulant therapy. [PDF]
Li HX +4 more
europepmc +1 more source
Differences in the Composition of Activated Partial Thromboplastin Time (APTT) Reagents Affect Clot Waveform Analysis. [PDF]
Kato K +4 more
europepmc +1 more source

